Search details
1.
Exosomes in multiple myeloma: from bench to bedside.
Blood
; 140(23): 2429-2442, 2022 12 08.
Article
in English
| MEDLINE | ID: mdl-35271699
2.
S-adenosylmethionine biosynthesis is a targetable metabolic vulnerability in multiple myeloma.
Haematologica
; 109(1): 256-271, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37470139
3.
Metformin confers sensitisation to syrosingopine in multiple myeloma cells by metabolic blockage and inhibition of protein synthesis.
J Pathol
; 260(2): 112-123, 2023 06.
Article
in English
| MEDLINE | ID: mdl-36807305
4.
Targeting the ß2 -adrenergic receptor increases chemosensitivity in multiple myeloma by induction of apoptosis and modulating cancer cell metabolism.
J Pathol
; 259(1): 69-80, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36245401
5.
Single-cell analysis at the protein level delineates intracellular signaling dynamic during hematopoiesis.
BMC Biol
; 19(1): 201, 2021 09 09.
Article
in English
| MEDLINE | ID: mdl-34503511
6.
Dendritic Cell-Based Immunotherapy in Multiple Myeloma: Challenges, Opportunities, and Future Directions.
Int J Mol Sci
; 23(2)2022 Jan 14.
Article
in English
| MEDLINE | ID: mdl-35055096
7.
The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
Br J Cancer
; 120(12): 1137-1146, 2019 06.
Article
in English
| MEDLINE | ID: mdl-31089208
8.
Tumour-associated macrophage-mediated survival of myeloma cells through STAT3 activation.
J Pathol
; 241(4): 534-546, 2017 03.
Article
in English
| MEDLINE | ID: mdl-27976373
9.
Metabolic Features of Multiple Myeloma.
Int J Mol Sci
; 19(4)2018 Apr 14.
Article
in English
| MEDLINE | ID: mdl-29662010
10.
Multiple myeloma exosomes establish a favourable bone marrow microenvironment with enhanced angiogenesis and immunosuppression.
J Pathol
; 239(2): 162-73, 2016 06.
Article
in English
| MEDLINE | ID: mdl-26956697
11.
Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells.
Blood
; 124(4): 555-66, 2014 Jul 24.
Article
in English
| MEDLINE | ID: mdl-24928860
12.
Stimulation of invariant natural killer T cells by α-Galactosylceramide activates the JAK-STAT pathway in endothelial cells and reduces angiogenesis in the 5T33 multiple myeloma model.
Br J Haematol
; 167(5): 651-63, 2014 Dec.
Article
in English
| MEDLINE | ID: mdl-25142285
13.
Activation of ATF4 mediates unwanted Mcl-1 accumulation by proteasome inhibition.
Blood
; 119(3): 826-37, 2012 Jan 19.
Article
in English
| MEDLINE | ID: mdl-22128141
14.
Hypoxic Bone Marrow Stromal Cells Secrete miR-140-5p and miR-28-3p That Target SPRED1 to Confer Drug Resistance in Multiple Myeloma.
Cancer Res
; 84(1): 39-55, 2024 01 02.
Article
in English
| MEDLINE | ID: mdl-37756570
15.
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia.
Theranostics
; 14(7): 2656-2674, 2024.
Article
in English
| MEDLINE | ID: mdl-38773967
16.
Bone marrow-derived mesenchymal stromal cells are attracted by multiple myeloma cell-produced chemokine CCL25 and favor myeloma cell growth in vitro and in vivo.
Stem Cells
; 30(2): 266-79, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22102554
17.
Tasquinimod suppresses tumor cell growth and bone resorption by targeting immunosuppressive myeloid cells and inhibiting c-MYC expression in multiple myeloma.
J Immunother Cancer
; 11(1)2023 01.
Article
in English
| MEDLINE | ID: mdl-36650020
18.
RNA-sequencing based first choice of treatment and determination of risk in multiple myeloma.
Front Immunol
; 14: 1286700, 2023.
Article
in English
| MEDLINE | ID: mdl-38035078
19.
Targeting S100A9 protein affects mTOR-ER stress signaling and increases venetoclax sensitivity in Acute Myeloid Leukemia.
Blood Cancer J
; 13(1): 188, 2023 12 18.
Article
in English
| MEDLINE | ID: mdl-38110349
20.
Dll1/Notch activation contributes to bortezomib resistance by upregulating CYP1A1 in multiple myeloma.
Biochem Biophys Res Commun
; 428(4): 518-24, 2012 Nov 30.
Article
in English
| MEDLINE | ID: mdl-23111325